期刊文献+

中国妇女使用狄波普维拉长效避孕针的多中心临床研究 被引量:2

The Multicenter Clinical Trial of Long-acting Injectable Contraceptive-Depo Provera in Chinese Women
在线阅读 下载PDF
导出
摘要 本研究为一开放性试验,1994例对象每3个月接受一次狄波普维拉避孕针注射,观察1年,共使用20294.3妇女月,仅发生1例意外妊娠,1年使用有效率为99.94%,总续用率为72.87%。该避孕针对体重和血压无明显影响,其主要副反应为卢、滴出血、出血期长、闭经等,也是停针的主要原因。随着继续用针,与出血问题有关的主诉会逐渐减少,而闭经主诉逐渐增加,哺乳妇女各种副反应发生率均较非哺乳妇女为低,连续用针率较高,绝大多数哺乳对象自觉对泌乳无影响。本研究结果表明,对于中国育龄妇女,使用狄波普维拉避孕针为一高度有效的避孕方法,在提供充分的咨询和服务条件下,使用得当,可有良好的可接受性,提高续用率,尤其适合哺乳妇女,可作为产后哺乳期避孕而推广使用。 This study was an open trial for one year, 1994 subjects received Depo Provera injectable contraceptive every three months and 20294. 3 women months were observed. At the time of observation,only one accident pregnancy occurred. The use-effectiveness rate was 99. 94 %. The cumulative continuation rate was 72. 87%. There were no significant adverse effects on body weight and blood pressure. The main side effects were spotting,prolonged bleeding and amenorrhea and thesewere also the main reasons for discontinuation. The complaints related to bleeding gradually decreased and the complaints of amenorrhea increased with continued use. In comparison with the non-lactating women,there was a lower occurrence of side effects and a higher continuation rate in the lactating women,meanwhile there was no effect on milk secretion of the breast. The results of this study indicated that Depo Provera is a very effective method for contraception. In a prerequisite of counseling,medical support and adequatl application of the drug,a high acceptability and continuation rate would be obtained. Depo Provera is especially more sutltable for the lactating women,and could be popularized as a contraceptive method during lactation period after parturition.
出处 《生殖与避孕》 CAS CSCD 北大核心 1999年第2期96-102,共7页 Reproduction and Contraception
关键词 狄波普维拉 避孕针 有效率 停针率 长效避孕针 Depo Provera injectahle contraceptive, Use-effectiveness rate, Discontinuation rate, Lactation
  • 相关文献

参考文献2

  • 1翁梨驹 经小萍 等.长效避孕针醋酸甲孕酮临床观察[J].北京医学,1987,9(5):287-287.
  • 2翁梨驹,北京医学,1987年,9卷,5期,287页

共引文献1

同被引文献5

  • 1翁梨驹 经小萍 张利嘉.长效避孕醋酸甲孕酮临床观察[J].北京医学,1987,9(5):287-288.
  • 2桑国卫 邵庆翔.中国妇女长效避孕针引入性试验研究[J].中华医学杂志,1998,34(9):230-231.
  • 3Salem HT, Salah M, Aly MY, et al. Acceptability of injectable Contraceptives in Assiut,Egypt. Contraception,1988.38 (6) :697 -698.
  • 4WHO Special Programme of Reaearch , Development and Research Training in Human Reproduction,Task Force on Long - Action Agents for the Regulation of Fertility :Multinatioal Comparative Clinical Trial:of Long- Acting Injectable Contraceptives: Norethisterone Enanthate Given in Two Dosage Regimens and Depot - Medroxyprogesterone Acetate Final Report. Contraception, 1983.28( 1 ) :1- 3.
  • 5WHO,Task France on Long--Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction:A Multicentred Phase Ⅲ Comparative Clinical Trial of Depot - Medroxyprogesterone Acetate Given Three -Monthly at Doses of 100mg or 150mg: 1. Contraceptive Efficacy and Side Effects. Contraception. 1996.34 (3) :223 - 224.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部